Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggressive Hydration vs Rectal Indomethacin for PEP Prevention
NCT03629600Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Oct 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lactated ringer's solution in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Post Graduate Institute of Medical Education and Research. Started Oct 2017; status: completed.
02
Drugs
lactated ringer's solution
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT03629600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03629600.